Collectively, our research on TSLP induction in breast cancer reveals that during the early stages of breast cancer development, cancer cells respond to TSLP-activated CD4+ T cell immunity by undergoing terminal differentiation (Boieri et al., 2022). The gene discussed is CD4; the disease is cancer.